Eurobotanicals

Eurobotanicals is a nutraceutical company that specialized in the development and marketing of botanical-based health products, primarily its proprietary Acai Juice Product. The company gained recognition in the medical community for its involvement in a Phase II clinical trial (NCT01521949) evaluating the efficacy of its antioxidant-rich acai juice in patients with biochemically recurrent prostate cancer. Although the trial did not meet its primary endpoint of a 50% reduction in PSA levels, it demonstrated a lengthening of PSA doubling time in a majority of participants. Historically, the company operated within the dietary supplement and multi-level marketing sectors, emphasizing the health benefits of the acai berry.